About this trial
The goal of this clinical trial is to learn if Aloe Vera gel dressing helps reduce pain better than traditional paraffin-based tulle dressing at the donor site of split-thickness skin grafts in adult patients aged 18 to 60. The main questions it aims to answer are:
Does Aloe Vera gel dressing reduce postoperative pain more effectively than paraffin-based tulle dressing on the 7th day after surgery?
Is there a difference in the need for additional pain medication between the two groups?
Researchers will compare Aloe Vera gel dressing to paraffin-based tulle dressing to see if Aloe Vera leads to better pain control.
Participants will:
Undergo split-thickness skin graft surgery
Receive either Aloe Vera gel dressing or paraffin-based tulle dressing at the donor site
Have pain measured using a visual analogue scale (VAS) on the 7th day after surgery
Be given pain medication if their pain score is 4 or higher, and the amount used will be recorded
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
• Patients aged 18-60 years of age of either gender needing Split thickness skin graft
Disqualifiers
• Patients known to have exaggerated/diminished pain response due to certain medical conditions (e.g. diabetes, neuropathy, chemotherapy, opioids etc.)
Patients allergic to either dressings
Trial design
Parallel
Treatments tested in this trial
Aloe Vera Gel Dressing
Other interventionParticipants in this arm will receive Aloe Vera gel applied directly to the split-thickness skin graft (STSG) donor site immediately after graft harvesting. The Aloe Vera gel will be applied in a sterile manner, followed by secondary dressing with dry gauze and crepe bandage. Pain will be assessed on postoperative day 7 using the Visual Analogue Scale (VAS).
Paraffin-Based Tulle Dressing
Other interventionParticipants in this arm will receive a conventional paraffin-based tulle dressing impregnated with chlorhexidine applied to the STSG donor site. The dressing will be followed by secondary coverage with dry gauze and crepe bandage. Pain will be assessed on postoperative day 7 using the Visual Analogue Scale (VAS).
Treatment groups
Trial outcomes
Primary outcomes
Pain Score at Donor Site on Postoperative Day 7
Postoperative pain will be measured using the Visual Analogue Scale (VAS), which ranges from 0 (no pain) to 10 (worst possible pain).
Sponsors and contacts
Click on the lead sponsor to view all of their trials.